Company Filing History:
Years Active: 2002-2009
Title: Innovations by Stefan Frederik Franciscus Verlinden
Introduction
Stefan Frederik Franciscus Verlinden is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical technology and gene delivery systems. With a total of two patents to his name, Verlinden's work showcases his innovative approach to solving complex problems in healthcare.
Latest Patents
One of Verlinden's latest patents is an "Expert system for medical diagnosis." This expert system is designed to assist in medical diagnosis by storing a variety of hypotheses in memory. The system categorizes these hypotheses into two disjoint groups and utilizes questions to reject those in the second group. The processor selects relevant questions based on initial data and determines the most likely hypothesis from the first group when no hypotheses from the second group are viable.
Another significant patent is for "Targeted delivery through a cationic amino acid transporter." This invention focuses on the targeted delivery of substances to cells using a virus-like particle or gene delivery vehicle. It features a ligand that binds to the human amino acid transporter, specifically the human transporter of cationic L-amino acids (hCAT1). This technology has potential applications in designing vector systems for efficient entry into human or primate cells.
Career Highlights
Throughout his career, Verlinden has worked with various companies, including Introgene B.V. and Vivici B.V. His experience in these organizations has contributed to his expertise in medical technology and gene delivery systems.
Collaborations
Some of Verlinden's notable coworkers include Helmuth Van Es and Menzo Jans Emco Havenga. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.
Conclusion
Stefan Frederik Franciscus Verlinden is a distinguished inventor whose work in medical diagnosis and targeted delivery systems has the potential to impact healthcare significantly. His innovative patents reflect his commitment to advancing technology for better health outcomes.